Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation

Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation

Inflammation is a key element in the pathobiology of neurodegenerative diseases and sees the involvement of different neuronal and non-neuronal cells as players able to respond to inflammatory signals of immune origin. Palmitoylethanolamide (PEA) is an endogenous potent anti-inflammatory agent, in w...

Full description

Bibliographic Details
Main Authors:	Giovanna Casili, Marika Lanza, Michela Campolo, Rosalba Siracusa, Irene Paterniti, Alessio Ardizzone, Sarah Adriana Scuderi, Salvatore Cuzzocrea, Emanuela Esposito
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	International Journal of Molecular Sciences
Subjects:	glioma neuroblastoma microglia oligodendrocytes neuroinflammation palmitoylethanolamide
Online Access:	https://www.mdpi.com/1422-0067/21/20/7486

Similar Items

Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury
by: Michela Campolo, et al.
Published: (2021-08-01)

PEA-OXA Mitigates Oxaliplatin-Induced Painful Neuropathy through NF-κB/Nrf-2 Axis
by: Michela Campolo, et al.
Published: (2021-04-01)

N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion
by: Daniela Impellizzeri, et al.
Published: (2019-05-01)

Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets
by: Alessio Filippo Peritore, et al.
Published: (2019-09-01)

Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
by: Paterniti Irene, et al.
Published: (2013-02-01)

Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-<span style="font-variant: small-caps">l</span>-Carnitine on Experimental Model of Inflammatory Pain
by: Alessio Ardizzone, et al.
Published: (2021-02-01)

Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury
by: Rosalia eCrupi, et al.
Published: (2016-03-01)

Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis
by: Michela Campolo, et al.
Published: (2020-05-01)

PEA/Polydatin: Anti-Inflammatory and Antioxidant Approach to Counteract DNBS-Induced Colitis
by: Alessio Filippo Peritore, et al.
Published: (2021-03-01)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
by: Stefania Petrosino, et al.
Published: (2018-03-01)

Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat
by: Alessio Filippo Peritore, et al.
Published: (2020-05-01)

The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats
by: Rosalba Siracusa, et al.
Published: (2020-10-01)

Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
by: Alessio Filippo Peritore, et al.
Published: (2021-05-01)

Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain
by: Marika Cordaro, et al.
Published: (2019-11-01)

Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia
by: Ramona D’Amico, et al.
Published: (2021-06-01)

Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease.
by: Irene Paterniti, et al.
Published: (2017-01-01)

Co-micronized palmitoylethanolamide/polydatin treatment causes endometriotic lesion regression in a rodent model of surgically-induced endometriosis
by: Rosanna Di Paola, et al.
Published: (2016-10-01)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
by: Ramona D’Amico, et al.
Published: (2020-07-01)

Oral Supplementation with Ultramicronized Palmitoylethanolamide for Joint Disease and Lameness Management in Four Jumping Horses: A Case Report
by: Enrico Gugliandolo, et al.
Published: (2020-08-01)

Management of Traumatic Brain Injury: From Present to Future
by: Rosalia Crupi, et al.
Published: (2020-04-01)

The Anti-Inflammatory and Antioxidant Effects of Sodium Propionate
by: Alessia Filippone, et al.
Published: (2020-04-01)

Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice
by: Giovanna Casili, et al.
Published: (2020-02-01)

Engineered <i>Lactobacillus paracasei</i> Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice
by: Giuseppe Esposito, et al.
Published: (2021-03-01)

Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries. A Systematic Review
by: Stefania Petrosino, et al.
Published: (2020-12-01)

Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing
by: Enrico Gugliandolo, et al.
Published: (2020-06-01)

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
by: Marika Cordaro, et al.
Published: (2020-03-01)

Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α
by: Scuderi Caterina, et al.
Published: (2012-03-01)

The Inhibition of Prolyl Oligopeptidase as New Target to Counteract Chronic Venous Insufficiency: Findings in a Mouse Model
by: Giovanna Casili, et al.
Published: (2020-12-01)

Modulation of NLRP3 Inflammasome Attenuated Inflammatory Response Associated to Diarrhea-Predominant Irritable Bowel Syndrome
by: Sarah Adriana Scuderi, et al.
Published: (2020-11-01)

Microglia and mast cells: new targets for the treatment of chronic pain
by: V.I. Romanenko
Published: (2021-06-01)

NUMMULAR HEADACHE – THREE YEARS LATER: WHAT HAPPENED
by: Domenico CHIRCHIGLIA, et al.
Published: (2020-03-01)

Short-term efficacy of a fixed association of Palmitoylethanolamide and other phytochemicals as add-on therapy in the management of chronic pain in elderly patients: a real-world retrospective study
by: Walter Gianni, et al.
Published: (2018-05-01)

Antioxidant and Anti-Inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
by: Sarah A. Scuderi, et al.
Published: (2020-07-01)

KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation
by: Sarah Adriana Scuderi, et al.
Published: (2021-07-01)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
by: Tai-Kyung Seol, et al.
Published: (2017-10-01)

Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study
by: Amanda Rao, et al.
Published: (2021-09-01)

Base- and acid-catalyzed interconversions of O-acyl- and N-acyl-ethanolamines: a cautionary note for lipid analyses
by: S.P. Markey, et al.
Published: (2000-04-01)

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
by: Annalisa Noce, et al.
Published: (2021-04-01)

A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models
by: Domenico Britti, et al.
Published: (2017-08-01)

TLR7/8 in the Pathogenesis of Parkinson’s Disease
by: Michela Campolo, et al.
Published: (2020-12-01)

Cannot write session to /tmp/vufind_sessions/sess_cl4pb7g6pjlkbun2vnh0nd57ek